Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001466116 | SCV001670115 | likely benign | Ataxia-telangiectasia syndrome | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002377789 | SCV002684793 | likely benign | Hereditary cancer-predisposing syndrome | 2021-03-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Genomic Medicine, |
RCV002465876 | SCV002760716 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003394066 | SCV004133282 | likely benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | ATM: PM2:Supporting, BP4, BP7 |
Myriad Genetics, |
RCV004591479 | SCV005082104 | benign | Familial cancer of breast | 2024-06-25 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |